查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1605708

核糖核酸市場，按類型、技術、交付方式、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Ribonucleic Acid Market, By Type, By Technology, By Delivery Method, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 345 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年核糖核酸市場規模為 3.45 億美元，2024 年至 2032 年複合年成長率為 8.5%。

核糖核酸市場-市場動態

對基因療法日益濃厚的興趣推動核糖核酸市場的擴張

人們對基因療法日益成長的興趣極大地促進了核糖核酸 (RNA) 市場的擴張，特別是隨著 mRNA 療法的進步。例如，2023 年，美國食品藥物管理局 (FDA) 批准了幾種新的基於 RNA 的治療方法，增強了遺傳性疾病和癌症的治療選擇。對基於 RNA 的研究投資的增加進一步促進了市場的成長，Moderna 和默克之間的合作等著名合作旨在利用 RNA 進行癌症治療。 mRNA 疫苗的成功，特別是在 COVID-19 大流行期間，進一步提高了人們的認知並加速了 RNA 技術在更廣泛的醫療應用中的探索。由於 RNA 有潛力透過針對遺傳疾病來徹底改變醫療保健，因此專注於 RNA 療法的研究經費和臨床試驗數量都出現了大幅成長。這一轉變與全球對個人化醫療和精準治療日益成長的興趣相一致，將 RNA 確立為現代生物技術的核心焦點。

核糖核酸市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.5% 左右的複合年成長率成長

根據類型細分，mRNA（信使 RNA）預計將在 2023 年顯示最大的市場佔有率

從技術細分來看，RNA定序是2023年的主導類型

根據遞送方式細分，脂質奈米顆粒是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

核糖核酸市場-細分分析：

全球核糖核酸市場根據類型、技術、交付方法、最終用戶和地區進行細分。

市場依類型分為三類：mRNA（信使RNA）、rRNA（核醣體RNA）和tRNA（轉移RNA）。 mRNA（信使RNA）因其在疫苗開發和基因治療中的突出作用而具有最高優先級。 rRNA（核醣體 RNA）對蛋白質合成至關重要，而 tRNA（轉移 RNA）則支持細胞過程中的翻譯。

根據技術，市場分為三類：RNA定序、基於PCR的RNA分析、微陣列分析。 RNA 定序因其分析轉錄組和基因表現的能力而成為領先技術。基於 PCR 的 RNA 分析是基因擴增的可靠方法，而微陣列分析則用於基因表現譜分析。

核糖核酸市場-地理洞察

在生物技術公司高度集中和對 RNA 研究的大量投資的推動下，北美目前在核糖核酸 (RNA) 市場中處於領先地位。 2023 年，mRNA 領域的主要參與者 Moderna 擴大了其在美國基於 mRNA 的疫苗生產設施，凸顯了該地區在 RNA 治療領域的主導地位。美國政府也增加了對 RNA 研究的資助，例如美國國立衛生研究院 (NIH) 對基因療法的投資等措施。歐洲緊隨其後，英國和德國等國家在基於 RNA 的藥物的臨床試驗和法規核准方面取得了重大進展。在亞太地區，中國和日本由於生物技術領域的不斷擴大，正在成為重要的參與者，日本將於2024 年批准第一個基於mRNA 的癌症疫苗。了診斷工具和基於 RNA 的藥物生產，促進了全球市場活動的增加。

核糖核酸市場-競爭格局：

北美繼續引領核糖核酸 (RNA) 市場的競爭格局，這主要是由 Moderna、輝瑞和 CureVac 等行業巨頭推動的。 2023 年，Moderna 將研究範圍擴大到基於 mRNA 的癌症疫苗，這是腫瘤學領域的重大舉措。輝瑞與 BioNTech 一起致力於推進其 RNA 疫苗產品組合，包括罕見遺傳性疾病的治療。在歐洲，BioNTech和阿斯特捷利康等公司正在積極開發RNA療法並在RNA疫苗研究方面進行合作。一項值得注意的合作關係是 BioNTech 與羅氏在 2024 年結盟，共同開發針對傳染病的 mRNA 疫苗。同時，在亞太地區，中國的科興生物正進入RNA治療領域，反映出該地區對生物技術的日益關注。該地區還受益於 RNA 研究的策略性投資以及大學和生物技術公司之間的合作。併購繼續影響市場，一些專注於 RNA 的小型新創公司被大型製藥公司收購，以增強其基於 RNA 的產品。

最新進展：

2024 年 9 月，Cytiva 為其 NanoAssemblr Ignite 平台推出了先進的 RNA 遞送 LNP 試劑盒。此創新試劑盒旨在增強 RNA 療法的配方和交付，簡化基於 mRNA 的療法的開發流程並改善患者的治療效果。

2024 年 10 月，Judo Bio 啟動了 A 系列融資，以推進其腎臟標靶 siRNA 療法。該計劃旨在開發腎臟疾病的創新療法，利用 RNA 技術改善患者的治療效果並解決腎臟健康方面未滿足的醫療需求。

目錄

第1章：核糖核酸市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的核糖核酸市場片段
    • 依技術分類的核糖核酸市場片段
    • 以交付方式分類的核糖核酸市場片段
    • 最終用戶的核糖核酸市場片段
    • 按國家分類的核糖核酸市場片段
    • 按地區分類的核糖核酸市場片段
  • 競爭洞察

第 3 章：核糖核酸主要市場趨勢

  • 核糖核酸市場促進因素
    • 市場促進因素的影響分析
  • 核糖核酸市場限制
    • 市場限制影響分析
  • 核糖核酸市場機會
  • 核糖核酸市場未來趨勢

第 4 章：核糖核酸產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：核糖核酸市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：核糖核酸市場格局

  • 2023 年核糖核酸市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：核糖核酸市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • mRNA（信使RNA）
    • rRNA（核醣體RNA）
    • tRNA（轉移RNA）
    • 其他

第 8 章：核糖核酸市場 - 依技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • RNA定序
    • 基於 PCR 的 RNA 分析
    • 微陣列分析

第 9 章：核糖核酸市場 - 依交付方式

  • 概述
    • 按交付方式分類的細分市場佔有率分析
    • 脂質奈米顆粒
    • 電穿孔
    • 病毒載體

第 10 章：核糖核酸市場 - 依最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥公司
    • 生技公司
    • 學術研究機構
    • 醫院和診斷實驗室

第 11 章：核糖核酸市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美核糖核酸主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按交付方式）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲核糖核酸主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按交付方式）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區核糖核酸主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模與預測（以交付方式）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲核糖核酸主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模和預測（以交付方式）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲核糖核酸主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（以交付方式）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 核糖核酸產業

  • 競爭儀表板
  • 公司簡介
    • Abcam Plc
    • Agilent Technologies, Inc.
    • Alnylam Pharmaceuticals, Inc.
    • BioNTech SE
    • Bio-Rad Laboratories Inc.
    • GSK plc
    • Illumina, Inc.
    • Ionis Pharmaceuticals, Inc.
    • Lonza Group Ltd.
    • Moderna, Inc.
    • Oxford Nanopore Technologies
    • Qiagen NV
    • Regeneron Pharmaceuticals, Inc.
    • Roche Diagnostics
    • Sarepta Therapeutics, Inc.
    • Thermo Fisher Scientific Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4353

REPORT HIGHLIGHT

Ribonucleic Acid Market size was valued at USD 345 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

The ribonucleic acid (RNA) market is primarily focused on the study and use of RNA molecules for various research, diagnostic, and therapeutic applications. RNA plays a critical role in cellular processes, and its potential in gene expression regulation and therapeutic delivery is expanding. Increased demand for RNA-based therapies, such as RNA vaccines, is a key factor behind the market's growth, as seen with the success of COVID-19 mRNA vaccines developed by companies like Moderna and Pfizer. Additionally, the growing interest in gene therapies, RNA interference (RNAi) treatments, and advancements in genomic research provide further momentum. However, challenges such as the high cost of RNA-based therapies and concerns about RNA stability and delivery methods hinder widespread adoption. Opportunities for growth exist in emerging markets, especially with increasing investments in biotech startups and expanding research in oncology, rare genetic disorders, and autoimmune diseases, where RNA-based treatments show significant promise. In 2023, investments in RNA technology increased by over 15%, reflecting a strong commitment to innovation.

Ribonucleic Acid Market- Market Dynamics

Growing Interest in Gene Therapies Drives Expansion in the Ribonucleic Acid Market

The growing interest in gene therapies is significantly contributing to the expansion of the ribonucleic acid (RNA) market, particularly with advancements in mRNA therapeutics. In 2023, for example, the U.S. Food and Drug Administration (FDA) approved several new RNA-based treatments, enhancing treatment options for genetic disorders and cancers. A rise in investments in RNA-based research is further bolstering the market's growth, with notable collaborations such as the partnership between Moderna and Merck, which aims to leverage RNA for cancer treatment. The success of mRNA vaccines, especially during the COVID-19 pandemic, has further raised awareness and accelerated the exploration of RNA technologies for broader medical applications. With the potential for RNA to revolutionize healthcare by targeting genetic diseases, there is substantial growth in both research funding and the number of clinical trials focused on RNA therapies. This shift aligns with a growing global interest in personalized medicine and precision treatments, establishing RNA as a core focus in modern biotechnology.

Ribonucleic Acid Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)

Based on Type segmentation, mRNA (messenger RNA) was predicted to show maximum market share in the year 2023

Based on Technology segmentation, RNA Sequencing was the leading type in 2023

Based on Delivery Method segmentation, Lipid nanoparticles were the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Ribonucleic Acid Market- Segmentation Analysis:

The Global Ribonucleic Acid Market is segmented on the basis of Type, Technology, Delivery Method, End-User, and Region.

The market is divided into three categories based on Type: mRNA (messenger RNA), rRNA (ribosomal RNA), and tRNA (transfer RNA). mRNA (messenger RNA) holds the highest priority due to its prominent role in vaccine development and gene therapies. rRNA (ribosomal RNA) follows as it is crucial for protein synthesis, while tRNA (transfer RNA) supports translation in cellular processes.

The market is divided into three categories based on Technology: RNA Sequencing, PCR-based RNA Analysis, and Microarray Analysis. RNA sequencing is the leading technology due to its ability to analyze transcriptomes and gene expression. PCR-based RNA analysis follows as a reliable method for gene amplification, while microarray analysis is used for gene expression profiling.

Ribonucleic Acid Market- Geographical Insights

North America is currently leading the ribonucleic acid (RNA) market, driven by the high concentration of biotech firms and substantial investments in RNA research. In 2023, Moderna, a key player in the mRNA space, expanded its mRNA-based vaccine production facilities in the U.S., underscoring the region's dominance in RNA therapeutics. The U.S. government has also increased funding for RNA research, with initiatives like the National Institutes of Health's (NIH) investment in gene-based therapies. Europe follows closely, with countries like the UK and Germany making significant strides in clinical trials and regulatory approvals for RNA-based drugs. In Asia-Pacific, China and Japan are emerging as important players due to their expanding biotech sectors, with Japan's approval of the first mRNA-based cancer vaccine in 2024. These regions are not only accelerating RNA-based therapies but also increasing the availability of diagnostic tools and RNA-based drug production, contributing to a global increase in market activity.

Ribonucleic Acid Market- Competitive Landscape:

North America continues to lead the competitive landscape of the ribonucleic acid (RNA) market, largely driven by industry giants like Moderna, Pfizer, and CureVac. In 2023, Moderna expanded its research into mRNA-based vaccines for cancer, a significant move in the oncology sector. Pfizer, alongside BioNTech, has focused on advancing its RNA vaccine portfolio, including treatments for rare genetic disorders. In Europe, companies such as BioNTech and AstraZeneca are actively developing RNA therapies and collaborating on RNA vaccine research. A notable partnership was the 2024 alliance between BioNTech and Roche to co-develop mRNA vaccines for infectious diseases. Meanwhile, in Asia-Pacific, China's Sinovac is entering the RNA therapeutics space, reflecting the region's growing focus on biotechnology. The region is also benefiting from strategic investments in RNA research and collaborations between universities and biotech firms. Mergers and acquisitions continue to shape the market, with several smaller RNA-focused startups being acquired by larger pharmaceutical companies to enhance their RNA-based offerings.

Recent Developments:

In September 2024, Cytiva launched an advanced RNA delivery LNP kit for its NanoAssemblr Ignite platform. This innovative kit is designed to enhance the formulation and delivery of RNA therapeutics, streamlining the development process for mRNA-based therapies and improving patient outcomes.

In October 2024, Judo Bio launched a Series A funding round to advance its kidney-targeted siRNA therapies. This initiative aims to develop innovative treatments for kidney diseases, leveraging RNA technology to improve patient outcomes and address unmet medical needs in renal health.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RIBONUCLEIC ACID MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abcam Plc
  • Agilent Technologies, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • BioNTech SE
  • Bio-Rad Laboratories Inc.
  • GSK plc
  • Illumina, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Lonza Group Ltd.
  • Moderna, Inc.
  • Oxford Nanopore Technologies
  • Qiagen N.V.
  • Regeneron Pharmaceuticals, Inc.
  • Roche Diagnostics
  • Sarepta Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL RIBONUCLEIC ACID MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • mRNA (messenger RNA)
  • rRNA (ribosomal RNA)
  • tRNA (transfer RNA)
  • Others

GLOBAL RIBONUCLEIC ACID MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • RNA Sequencing
  • PCR-based RNA Analysis
  • Microarray Analysis

GLOBAL RIBONUCLEIC ACID MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Lipid Nanoparticles
  • Electroporation
  • Viral Vectors

GLOBAL RIBONUCLEIC ACID MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Research Institutes
  • Hospitals & Diagnostic Laboratories

GLOBAL RIBONUCLEIC ACID MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Ribonucleic Acid Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Ribonucleic Acid Market Snippet by Type
    • 2.1.2. Ribonucleic Acid Market Snippet by Technology
    • 2.1.3. Ribonucleic Acid Market Snippet by Delivery Method
    • 2.1.4. Ribonucleic Acid Market Snippet by End-User
    • 2.1.5. Ribonucleic Acid Market Snippet by Country
    • 2.1.6. Ribonucleic Acid Market Snippet by Region
  • 2.2. Competitive Insights

3. Ribonucleic Acid Key Market Trends

  • 3.1. Ribonucleic Acid Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Ribonucleic Acid Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Ribonucleic Acid Market Opportunities
  • 3.4. Ribonucleic Acid Market Future Trends

4. Ribonucleic Acid Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Ribonucleic Acid Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Ribonucleic Acid Market Landscape

  • 6.1. Ribonucleic Acid Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Ribonucleic Acid Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. mRNA (messenger RNA)
    • 7.1.3. rRNA (ribosomal RNA)
    • 7.1.4. tRNA (transfer RNA)
    • 7.1.5. Others

8. Ribonucleic Acid Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. RNA Sequencing
    • 8.1.3. PCR-based RNA Analysis
    • 8.1.4. Microarray Analysis

9. Ribonucleic Acid Market - By Delivery Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 9.1.2. Lipid Nanoparticles
    • 9.1.3. Electroporation
    • 9.1.4. Viral Vectors

10. Ribonucleic Acid Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Academic Research Institutes
    • 10.1.5. Hospitals & Diagnostic Laboratories

11. Ribonucleic Acid Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Ribonucleic Acid Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Ribonucleic Acid Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Ribonucleic Acid Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Ribonucleic Acid Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Ribonucleic Acid Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Ribonucleic Acid Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abcam Plc
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. Alnylam Pharmaceuticals, Inc.
    • 12.2.4. BioNTech SE
    • 12.2.5. Bio-Rad Laboratories Inc.
    • 12.2.6. GSK plc
    • 12.2.7. Illumina, Inc.
    • 12.2.8. Ionis Pharmaceuticals, Inc.
    • 12.2.9. Lonza Group Ltd.
    • 12.2.10. Moderna, Inc.
    • 12.2.11. Oxford Nanopore Technologies
    • 12.2.12. Qiagen N.V.
    • 12.2.13. Regeneron Pharmaceuticals, Inc.
    • 12.2.14. Roche Diagnostics
    • 12.2.15. Sarepta Therapeutics, Inc.
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us